Aleix Prat
- Specialization: Clinical oncologist
- 23 years of experience
- Speaks:English, Spanish
- Online consultations: available
- Workplace: Spain, Barcelona, Hospital Quiron Barcelona
- President of the Board of Directors of SOLTI
The doctor is a clinical scientist with expertise in the clinical application of laboratory findings in breast cancer, focusing on gene expression and molecular subtypes. The doctor designs and leads clinical trials for novel drugs and approaches at SOLTI, a Spanish breast cancer cooperative group.
Graduating with an MD from the University of Barcelona in 2003, the doctor completed a medical oncology fellowship at Vall d'Hebron Institute of Oncology and postdoctoral research at the University of North Carolina.
Currently, the doctor heads the Translational Genomics and Targeted Therapeutics in Solid Tumors Group at IDIBAPS and is the President of SOLTI's Board of Directors. The doctor has co-founded Reveal Genomics and holds three patents.
With over 160 publications and an H-Index of 51, the doctor has been cited 13,479 times and has presented 95 communications internationally.
Online consultation with Aleix Prat
Patient reviews
Doctor's services
How are we doing?
Qualifications
Dr. Prat is a clinical scientist with a longstanding research interest in the clinical application of laboratory findings in breast cancer, with a particular interest in gene expression and the clinical implications of different intrinsic molecular subtypes of breast cancer and also he designs and leads clinical trials of novel drugs and approaches at SOLTI, a Spanish breast cancer cooperative group.
Formation
- MD degree in 2003 from the University of Barcelona.
- medical oncology fellowship in 2008 at Vall d´Hebron Institute of Oncology (VHIO).
- postdoctoral research associate at the Lineberger Comprehensive Cancer Center (University of North Carolina at Chapel Hill, USA) in the Laboratory of Prof. Charles M. Perou, in 2008.
Track
- Head of the Translational Genomics and Targeted Therapeutics in Solid Tumors Group at August Pi i Sunyer Biomedical Research Institute (IDIBAPS).
- President of the Board of Directors of SOLTI.
- member of the Executive Committee of The Breast International Group (BIG) in 2018.
- co-founder of the spin-off called Reveal Genomics, SL.
- holds three issued patents, which certificates a stable scientific career.
- Head of the Translational Genomics Group at VHIO (2012).
- Hospital Clínic and IDIBAPS (2014).
Publications
Part of more than 160 publications (H-Index Score of 51), with a total of 13.479 citations and 95 communications in international conferences.
Teaching
- Tenure-Track Professor of Barcelona University (UB)
- Director, Breast Pathology – Senology Master´s degree, UB.
You may also be interested
Payment & Rewards
You don’t pay for our services
You make your payment directly at the clinic or to their official bank account.
Some clinics may require a deposit as a part of their policy.
Spread out your payments with installment options.
Earn rewards for referring friends to Bookimed.